Cough Reduction in Patients With Refractory Chronic Cough Following Administration of NAL ER Versus Placebo

Condition:   Refractory Chronic Cough Interventions:   Drug: Nalbuphine Hydrochloride;   Drug: Placebo Sponsor:   Trevi Therapeutics Not yet recruiting

Source: ClinicalTrials.gov - July 27, 2023 Category: Research Source Type: clinical trials